Welcome to Paid Research Studies




  • Condition:   Endophthalmitis
    Interventions:   Drug: Moxifloxacin;   Drug: Placebo
    Sponsor:   Jason Ahee, M.D.
    Not yet recruiting

  • Condition:   Healthy Volunteers
    Interventions:   Drug: Balovaptan therapeutic dose Treatment A;   Drug: Balovaptan supra-therapeutic dose Treatment B;   Drug: Active control [moxifloxacin] on Day 2 Treatment C;   Drug: Active control [moxifloxacin] on Day 15 Treatment D;   Drug: Placebo for Balovaptan Treatment C;   Drug: Placebo for Balovaptan Treatment D;   Drug: Placebo for Moxifloxacin Treatment A;   Drug: Placebo for moxifloxacin Treatment B;   Drug: Moxifloxacin Treatment C;   Drug: Placebo for moxifloxacin Treatment C;   Drug: Placebo for moxifloxacin Treatment D;   Drug: Moxifloxacin Treatment D
    Sponsor:   Hoffmann-La Roche
    Recruiting

  • Condition:   Pediatric ALL
    Intervention:   Drug: Standard of care drug
    Sponsor:   Duke University
    Recruiting

  • Condition:   Appendicitis
    Interventions:   Drug: Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin;   Procedure: Appendectomy
    Sponsors:   University of Washington;   Patient-Centered Outcomes Research Institute
    Recruiting

  • Condition:   Osteomyelitis
    Interventions:   Drug: oral antibiotics;   Procedure: intravenous antibiotics
    Sponsors:   Julio Ramirez;   University of Louisville
    Recruiting

  • Condition:   HIV Infections
    Interventions:   Drug: atazanavir/cobicistat;   Drug: darunavir/ritonavir;   Drug: darunavir/cobicistat;   Drug: etravirine;   Drug: elvitegravir/cobicistat;   Drug: dolutegravir;   Drug: tenofovir alafenamide fumarate (TAF);   Drug: TAF/cobicistat;   Drug: TAF/ritonavir;   Drug: efavirenz;   Drug: lopinavir/ritonavir;   Drug: nevirapine;   Drug: rifampicin;   Drug: ethambutol;   Drug: isoniazid;   Drug: pyrazinamide;   Drug: kanamycin;   Drug: amikacin;   Drug: capreomycin;   Drug: moxifloxacin;   Drug: levofloxacin;   Drug: ofloxacin;   Drug: ethionamide/prothionamide;   Drug: terizidone/cycloserine;   Drug: para-aminosalicylic acid (PAS);   Drug: high dose isoniazid (INH);   Drug: bedaquiline;   Drug: clofazamine;   Drug: delamanid;   Drug: linezolid;   Drug: pretomanid;   Drug: atazanavir/ritonavir/tenofovir;   Drug: ethinyl estradiol oral contraceptive;   Drug: etonogestrel implant
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting